Nutanix Inc. (NASDAQ:NTNX) saw a 7.24% increase in shares on Monday, closing at $74.98 apiece, following news of its inclusion in the S&P MidCap 400 index at the end of the month, replacing Acadia Healthcare Company.

The announcement of Nutanix Inc. (NASDAQ:NTNX) joining the S&P MidCap 400 index is expected to provide the company with increased exposure to institutional investors and hedge funds, potentially leading to more investment opportunities.

Despite recent gains and positive developments, Nutanix Inc. (NASDAQ:NTNX) reported a net loss of $126 million in the second quarter, a significant decrease from the previous year’s net income of $38.65 million, with total revenues also dropping by 16% year-on-year.

While NTNX shows potential as an investment, some AI stocks may offer greater returns with limited risk. For those seeking opportunities in the AI sector, a free report on the best short-term AI stock is available, highlighting a stock poised to benefit from current economic trends.

Read more at Yahoo Finance: Nutanix (NTNX) Jumps as Firm Joins S&P Club